A licensing deal with Jiangsu Hengrui Pharmaceuticals puts Merck in a competitive race to develop a medicine that targets a ...

Merck (NYSE:MRK) stock in focus as the company partners with Jiangsu Hengrui in a $2B deal for heart disease therapy HRS-5346 ...

Cervical cancer is one of the most preventable cancers, although recent research suggests that the United States is ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats. Trump ...

In what’s shaping up to be a red-letter week for Gardasil, Merck & Co. has simultaneously opened a massive new manufacturing facility for the human papillomavirus (HPV) shot in the U.S. and put ...

According to Judge Kenneth Bell, there is a lack of evidence to conclude that Merck willingly misrepresented the safety of its HPV vaccine Gardasil to patients and prescribers. A federal court ruled ...

Merck has opened a $1 billion, 225,000-square-foot facility at its Durham campus dedicated to vaccine manufacturing, the drug giant announced Tuesday. Merck has opened a $1 billion, 225,000-square ...

Please visit the Merck media library for images and b-roll of the new Durham facility. About Merck At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We ...

Please visit the Merck media library for images and b-roll of the new Durham facility.

March 11 (Reuters) - Merck (MRK.N), opens new tab said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid ...

DURHAM, N.C. (WTVD) -- Drugmaker Merck announced Tuesday the opening of a new facility in North Durham. The $1 billion plant will manufacture the HPV vaccines Gardasil and Gardasil 9, while the ...